• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT
Click for more information
0.00% 1.9¢

SYNTARA LIMITED - News & Media

Market Cap $22.68M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug... Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. Its lead candidate, PXS-5505, is used for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its PXS-4728 is a SSAO/MAOB inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis, and cardiac fibrosis. It has developed two respiratory products: Bronchitol, for cystic fibrosis, and Aridol, a lung function test.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
1.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $22.68M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $30.40K 1.594M

Buyers (Bids)

No. Vol. Price($)
4 843043 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1080275 5
View Market Depth
Last trade - 16.10pm 24/05/2024 (20 minute delay) ?
Last
1.9¢ 		  Change
0.000 ( 5.00 %)
Open High Low Volume
2.0¢ 2.0¢ 1.9¢ 141350
Last updated 15.46pm 24/05/2024 ?
SNT (ASX) Chart

Top Stories

The Telstra twist - What the job cuts decision mean for investors?

Telstra (ASX:TLS) made headlines last week by announcing significant job cuts of up to 2,800 positions as part of cost-saving measures. This decision resulted in one of the largest weekly declines in its share price since 2020 and raised questions about whether this presents an opportunity to acq...
Nimy seeks massive sulphide systems through surveying at WA prospects Nimy Resources has begun a series of geophysical surveys and says it has discovered a 3,004km2 greenstone belt in Western Australia.
Althea on a high as it opens cannabis drinks in the US with Flora Growth Peak Processing has joined forces with Flora Growth to introduce cannabis drinks to the US beverages market.
PlaySide to take gamers back to Westeros with new PC title PlaySide Studios Ltd are set to produce a new game developed around award-winning TV program Game of Thrones.
KalGold hits more than 3g/t gold at Wessex target in WA Kalgoorlie Gold Mining Ltd has reported shallow and thick zones of gold grading above 3 grams per tonne at its Wessex target in WA.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.